Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2006 4
2007 4
2008 1
2009 5
2010 3
2011 1
2012 1
2013 6
2014 5
2015 4
2016 3
2017 4
2018 1
2019 4
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

49 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean huiqian yu (33 results)?
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients.
Su HX, Yao S, Zhao WF, Li MJ, Liu J, Shang WJ, Xie H, Ke CQ, Hu HC, Gao MN, Yu KQ, Liu H, Shen JS, Tang W, Zhang LK, Xiao GF, Ni L, Wang DW, Zuo JP, Jiang HL, Bai F, Wu Y, Ye Y, Xu YC. Su HX, et al. Acta Pharmacol Sin. 2020 Sep;41(9):1167-1177. doi: 10.1038/s41401-020-0483-6. Epub 2020 Jul 31. Acta Pharmacol Sin. 2020. PMID: 32737471 Free PMC article.
Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs.
Li Z, Li X, Huang YY, Wu Y, Liu R, Zhou L, Lin Y, Wu D, Zhang L, Liu H, Xu X, Yu K, Zhang Y, Cui J, Zhan CG, Wang X, Luo HB. Li Z, et al. Among authors: yu k. Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27381-27387. doi: 10.1073/pnas.2010470117. Epub 2020 Oct 13. Proc Natl Acad Sci U S A. 2020. PMID: 33051297 Free PMC article.
49 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page